U.S. markets closed

Anavex Life Sciences Corp. (AVXL)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
11.80-0.32 (-2.64%)
At close: 4:00PM EDT
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Breakdown
ttm
9/30/2020
9/30/2019
9/30/2018
9/30/2017
Total Revenue
0
0
0
0
0
Operating Expense
32,709
30,938
28,808
19,185
15,539
Operating Income
-32,709
-30,938
-28,808
-19,185
-15,539
Net Non Operating Interest Income Expense
131.694
179.973
56.147
224.149
88.098
Other Income Expense
5,106
4,501
2,539
1,580
2,051
Pretax Income
-27,471
-26,258
-26,213
-17,381
-13,401
Tax Provision
72.731
22.664
82.181
72.746
59.607
Net Income Common Stockholders
-27,544
-26,280
-26,295
-17,453
-13,460
Diluted NI Available to Com Stockholders
-27,544
-26,280
-26,295
-17,453
-13,460
Basic EPS
-
-0.45
-0.54
-0.39
-0.33
Diluted EPS
-
-0.45
-0.54
-0.39
-0.33
Basic Average Shares
-
58,195
48,906
44,656
40,841
Diluted Average Shares
-
58,195
48,906
44,656
40,841
Total Expenses
32,709
30,938
28,808
19,185
15,539
Net Income from Continuing & Discontinued Operation
-27,544
-26,280
-26,295
-17,453
-13,460
Normalized Income
-27,839
-26,372
-26,349
-17,417
-13,477
Interest Income
-
179.973
207.28
255.092
88.098
Net Interest Income
131.694
179.973
56.147
224.149
88.098
EBIT
-32,709
-30,938
-28,808
-19,185
-15,539
EBITDA
-32,709
-
-
-
-
Reconciled Depreciation
-
-
-
0
-
Net Income from Continuing Operation Net Minority Interest
-27,544
-26,280
-26,295
-17,453
-13,460
Total Unusual Items Excluding Goodwill
405.061
125.54
73.369
-49.789
27.621
Total Unusual Items
405.061
125.54
73.369
-49.789
27.621
Normalized EBITDA
-33,114
-31,064
-28,881
-19,135
-15,567
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
109.3665
33.8958
19.8096
-13.443
11.0484